Get startedLog in
    Picture of PhaseBio Pharmaceuticals logo

    PHASQ — PhaseBio Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Phasebio Reports Third-Quarter 2021 Financial Results And Recent Business Highlights

    Picture of PhaseBio Pharmaceuticals logoPhaseBio Pharmaceuticals
    10/11/2021 21:03
    Nov 10 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO REPORTS THIRD-QUARTER 2021 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
    * CASH AND CASH EQUIVALENTS AT SEPTEMBER 30, 2021 WERE $56.4
MILLION
    * QTRLY LOSS PER SHARE $0.66
    * Q3 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwcdXNyga 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PhaseBio Pharmaceuticals

    See all news